← Eichor
Condition: Uveitis Anterior Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Uveitis Anterior

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT01746537Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Phase 3 · 7 location(s) · Amgen · NCT05767047Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
Phase 2 · 6 location(s) · Novaliq GmbH · NCT07285070AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715Vasculitis Pregnancy Registry
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02593565Deployment o the Multidisciplinary Prospective Cohort Imminent
NA · 1 location(s) · University Hospital, Lille · NCT04334031Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis
Phase N/A · 1 location(s) · Marmara University · NCT06720376Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus
NA · 2 location(s) · Cairo University · NCT07702149Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Contro
Phase N/A · 1 location(s) · ÖZLEM NUR TOK YAMAN · NCT07276087Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT07065747Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
Phase N/A · 1 location(s) · Sohag University · NCT06721234Baricitinib in the Treatment of Intestinal Behçet's Syndrome
Phase 2 · 2 location(s) · Peking Union Medical College Hospital · NCT06849908The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterio
Phase 3 · 1 location(s) · Texas Retina Associates · NCT05486468Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
Phase 2 · 6 location(s) · UMC Utrecht · NCT06285539EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07077304Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing
NA · 1 location(s) · Cairo University · NCT07662603Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Phase N/A · 6 location(s) · Santé Arménie French-Armenian Research Center · NCT05904301A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU
Phase 2 · 1 location(s) · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd · NCT07552012Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease
NA · 1 location(s) · Cairo University · NCT07702123Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep V
Phase 3 · 17 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06780462Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · 27 location(s) · Amgen · NCT04528082A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
Phase 3 · 22 location(s) · Ganzhou Hemay Pharmaceutical Co., Ltd · NCT06145893Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease
NA · 2 location(s) · Meyer Children's Hospital IRCCS · NCT07375940German Spondyloarthritis Inception Cohort
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT01277419BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06794008Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT05845723Ustekinumab in BEhçet's Syndrome STudy
Phase N/A · 11 location(s) · Groupe français d'étude des Maladies Inflammatoires de loeil · NCT07244614
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.